ClariTrial | Search Clinical Trials

Explore/cancer oncology

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

6,381 results for “cancer oncology” · Recruiting · Phase 3 · Phase 2

Page 1 of 426

Recruiting

A Study of Fruquintinib Plus Chemotherapy for Postoperative Treatment of HER2-Negative Gastric Cancer With Poor TRG

Phase 2Gastric/Gastroesophageal Junction Adenocarcinoma

Fruquintinib

Henan Cancer Hospital69 participants1 site · ChinaCompletes Dec 2025

Compare CT.gov Full analysis →

Recruiting

Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)

Phase 2Prostate AdenocarcinomaMetastatic Prostate AdenocarcinomaCastration-resistant

radium-223Bipolar Androgen Therapy (BAT)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins47 participants2 sites · United States, BrazilCompletes Feb 2028

Compare CT.gov Full analysis →

Recruiting

Photodynamic Therapy Associated With Sonodynamic Therapy for the Treatment of Nodular Basal Cell Carcinoma

Phase 3Nodular Basal Cell Carcinoma of Skin

Control Arm (Conventional Therapy)Experimental arm

University of Sao Paulo142 participants1 site · BrazilCompletes Aug 2026

Compare CT.gov Full analysis →

Recruiting

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Phase 3Prostate Cancer

AAA817ARPIStandard of Care

Novartis Pharmaceuticals940 participants106 sites · United States, Australia, BrazilCompletes Sep 2028

Compare CT.gov Full analysis →

Recruiting

Bronchial NIR Image-guided Resection

Phase 1Phase 2Sentinel Lymph Node

ICG InterventionNear Infrared Imaging

Massachusetts General Hospital100 participants1 site · United StatesCompletes Jan 2027

Compare CT.gov Full analysis →

Recruiting

Fluorescent Intra-operative Tumor Margin Examination

Phase 2Sarcoma

Indocyanine green solution administered at 2.0mg/kg.Stryker SPY-PHI Imaging Device

Kurt Weiss110 participants1 site · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

The Combination of Radiotherapy，Surufatinib and Sintilimab in High-Risk Localized Soft Tissue Sarcoma

Phase 1Phase 2High-Risk Localized Soft Tissue Sarcoma

SurufatinibSintilimabRadiotherapy

Fudan University52 participants1 site · ChinaCompletes Jul 2024

Compare CT.gov Full analysis →

Recruiting

MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL)

Phase 1Phase 2Follicular Lymphoma and Marginal Zone Lymphoma

Recombinant Humanized Monoclonal Antibody MIL62 InjectionLenalidomide

Beijing Mabworks Biotech Co., Ltd.53 participants1 site · ChinaCompletes Jan 2024

Compare CT.gov Full analysis →

Recruiting

A Study to Assess the Efficacy and Safety of Firmonertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB - IIIB NSCLC With Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations, Following Complete Surgical Resection With or Without Adjuvant Chemotherapy（FIRMOST）

Phase 3NSCLCAdjuvant Treatment

FirmonertinibPlacebo

Allist Pharmaceuticals, Inc.338 participants2 sites · ChinaCompletes Oct 2028

Compare CT.gov Full analysis →

Recruiting

Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.

Phase 2Phase 3Rectal CancerTotal Neoadjuvant TreatmentNeoadjuvant Therapy

Radiation TherapyChemoradiotherapyConsolidation Chemotherapy+3 more

National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos400 participants1 site · LithuaniaCompletes Dec 2029

Compare CT.gov Full analysis →

Recruiting

Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)

Phase 2Colorectal Cancer Metastatic

isunakinra

Buzzard Pharmaceuticals20 participants3 sites · United StatesCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis

Phase 2Primary MyelofibrosisSecondary Myelofibrosis

CyclophosphamideJAK InhibitorFludarabine+13 more

Fred Hutchinson Cancer Center20 participants1 site · United StatesCompletes Apr 2027

Compare CT.gov Full analysis →

Recruiting

Human Upper Extremity Allotransplantation

Phase 2Amputation, TraumaticWounds and InjuriesHand Injuries

Deceased donor hand transplantationBone marrow cell-based therapy & single-drug immunosuppression.

Johns Hopkins University30 participants1 site · United StatesCompletes Jun 2036

Compare CT.gov Full analysis →

Recruiting

Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer

Phase 2Larynx CancerHypopharyngeal Cancer

SurgeryRadiationToripalimab

Fudan University82 participants1 site · ChinaCompletes Sep 2027

Compare CT.gov Full analysis →

Recruiting

Phase II Study of PD-1 Antibody Combined With Radiotherapy in Recurrent or Metastatic Adrenal Cortical Carcinoma

Phase 2Adrenocortical Carcinoma

Triprolizumabrodiotherapy

Sun Yat-sen University18 participants1 site · ChinaCompletes Mar 2027

Compare CT.gov Full analysis →

1–15 of 6,381

Explore/cancer oncology

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

6,381 results for “cancer oncology” · Recruiting · Phase 3 · Phase 2

Page 1 of 426

Recruiting

A Study of Fruquintinib Plus Chemotherapy for Postoperative Treatment of HER2-Negative Gastric Cancer With Poor TRG

Phase 2Gastric/Gastroesophageal Junction Adenocarcinoma

Fruquintinib

Henan Cancer Hospital69 participants1 site · ChinaCompletes Dec 2025

Compare CT.gov Full analysis →

Recruiting

Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)

Phase 2Prostate AdenocarcinomaMetastatic Prostate AdenocarcinomaCastration-resistant

radium-223Bipolar Androgen Therapy (BAT)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins47 participants2 sites · United States, BrazilCompletes Feb 2028

Compare CT.gov Full analysis →

Recruiting

Photodynamic Therapy Associated With Sonodynamic Therapy for the Treatment of Nodular Basal Cell Carcinoma

Phase 3Nodular Basal Cell Carcinoma of Skin

Control Arm (Conventional Therapy)Experimental arm

University of Sao Paulo142 participants1 site · BrazilCompletes Aug 2026

Compare CT.gov Full analysis →

Recruiting

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Phase 3Prostate Cancer

AAA817ARPIStandard of Care

Novartis Pharmaceuticals940 participants106 sites · United States, Australia, BrazilCompletes Sep 2028

Compare CT.gov Full analysis →

Recruiting

Bronchial NIR Image-guided Resection

Phase 1Phase 2Sentinel Lymph Node

ICG InterventionNear Infrared Imaging

Massachusetts General Hospital100 participants1 site · United StatesCompletes Jan 2027

Compare CT.gov Full analysis →

Recruiting

Fluorescent Intra-operative Tumor Margin Examination

Phase 2Sarcoma

Indocyanine green solution administered at 2.0mg/kg.Stryker SPY-PHI Imaging Device

Kurt Weiss110 participants1 site · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

The Combination of Radiotherapy，Surufatinib and Sintilimab in High-Risk Localized Soft Tissue Sarcoma

Phase 1Phase 2High-Risk Localized Soft Tissue Sarcoma

SurufatinibSintilimabRadiotherapy

Fudan University52 participants1 site · ChinaCompletes Jul 2024

Compare CT.gov Full analysis →

Recruiting

MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL)

Phase 1Phase 2Follicular Lymphoma and Marginal Zone Lymphoma

Recombinant Humanized Monoclonal Antibody MIL62 InjectionLenalidomide

Beijing Mabworks Biotech Co., Ltd.53 participants1 site · ChinaCompletes Jan 2024

Compare CT.gov Full analysis →

Recruiting

Phase 3NSCLCAdjuvant Treatment

FirmonertinibPlacebo

Allist Pharmaceuticals, Inc.338 participants2 sites · ChinaCompletes Oct 2028

Compare CT.gov Full analysis →

Recruiting

Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.

Phase 2Phase 3Rectal CancerTotal Neoadjuvant TreatmentNeoadjuvant Therapy

Radiation TherapyChemoradiotherapyConsolidation Chemotherapy+3 more

National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos400 participants1 site · LithuaniaCompletes Dec 2029

Compare CT.gov Full analysis →

Recruiting

Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)

Phase 2Colorectal Cancer Metastatic

isunakinra

Buzzard Pharmaceuticals20 participants3 sites · United StatesCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis

Phase 2Primary MyelofibrosisSecondary Myelofibrosis

CyclophosphamideJAK InhibitorFludarabine+13 more

Fred Hutchinson Cancer Center20 participants1 site · United StatesCompletes Apr 2027

Compare CT.gov Full analysis →

Recruiting

Human Upper Extremity Allotransplantation

Phase 2Amputation, TraumaticWounds and InjuriesHand Injuries

Deceased donor hand transplantationBone marrow cell-based therapy & single-drug immunosuppression.

Johns Hopkins University30 participants1 site · United StatesCompletes Jun 2036

Compare CT.gov Full analysis →

Recruiting

Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer

Phase 2Larynx CancerHypopharyngeal Cancer

SurgeryRadiationToripalimab

Fudan University82 participants1 site · ChinaCompletes Sep 2027

Compare CT.gov Full analysis →

Recruiting

Phase II Study of PD-1 Antibody Combined With Radiotherapy in Recurrent or Metastatic Adrenal Cortical Carcinoma

Phase 2Adrenocortical Carcinoma

Triprolizumabrodiotherapy

Sun Yat-sen University18 participants1 site · ChinaCompletes Mar 2027

Compare CT.gov Full analysis →

1–15 of 6,381